Michel Weiwer - Publications

Affiliations: 
2005-2008 Rensselaer Polytechnic Institute, Troy, NY, United States 

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wagner FF, Weïwer M, Steinbacher S, Schomburg A, Reinemer P, Gale JP, Campbell AJ, Fisher SL, Zhao WN, Reis SA, Hennig KM, Thomas M, Müller P, Jefson MR, Fass DM, et al. Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors. Bioorganic & Medicinal Chemistry. PMID 27377864 DOI: 10.1016/J.Bmc.2016.06.040  0.333
2015 Wagner FF, Zhang YL, Fass DM, Joseph N, Gale JP, Weïwer M, McCarren P, Fisher SL, Kaya T, Zhao WN, Reis SA, Hennig KM, Thomas M, Lemercier BC, Lewis MC, et al. Kinetically Selective Inhibitors of Histone Deacetylase 2 (HDAC2) as Cognition Enhancers. Chemical Science (Royal Society of Chemistry : 2010). 6: 804-815. PMID 25642316 DOI: 10.1039/C4Sc02130D  0.311
2015 Benajiba L, Wagner F, Ross L, Galinsky I, DeAngelo DJ, Gale J, Pan J, Zhang Y, Sacher J, Weiwer M, Stone RM, Holson E, Stegmaier K. Identification of a First in Class GSK3-Alpha Selective Inhibitor As a New Differentiation Therapy for AML Blood. 126: 870-870. DOI: 10.1182/Blood.V126.23.870.870  0.35
2013 Olson DE, Wagner FF, Kaya T, Gale JP, Aidoud N, Davoine EL, Lazzaro F, Weïwer M, Zhang YL, Holson EB. Discovery of the first histone deacetylase 6/8 dual inhibitors. Journal of Medicinal Chemistry. 56: 4816-20. PMID 23672185 DOI: 10.1021/Jm400390R  0.354
2013 Wagner FF, Olson DE, Gale JP, Kaya T, Weïwer M, Aidoud N, Thomas M, Davoine EL, Lemercier BC, Zhang YL, Holson EB. Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif. Journal of Medicinal Chemistry. 56: 1772-6. PMID 23368884 DOI: 10.1021/Jm301355J  0.368
2012 Weïwer M, Spoonamore J, Wei J, Guichard B, Ross NT, Masson K, Silkworth W, Dandapani S, Palmer M, Scherer CA, Stern AM, Schreiber SL, Munoz B. A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells. Acs Medicinal Chemistry Letters. 3: 1034-1038. PMID 23256033 DOI: 10.1021/Ml300246R  0.335
2012 Dockendorff C, Nagiec MM, Weïwer M, Buhrlage S, Ting A, Nag PP, Germain A, Kim HJ, Youngsaye W, Scherer C, Bennion M, Xue L, Stanton BZ, Lewis TA, Macpherson L, et al. Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies. Acs Medicinal Chemistry Letters. 3: 808-813. PMID 23074541 DOI: 10.1021/Ml300172P  0.349
2012 Heidebrecht RW, Mulrooney C, Austin CP, Barker RH, Beaudoin JA, Cheng KC, Comer E, Dandapani S, Dick J, Duvall JR, Ekland EH, Fidock DA, Fitzgerald ME, Foley M, Guha R, et al. Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria. Acs Medicinal Chemistry Letters. 3: 112-117. PMID 22328964 DOI: 10.1021/Ml200244K  0.325
2012 Masuko S, Bera S, Green DE, Weïwer M, Liu J, Deangelis PL, Linhardt RJ. Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans Journal of Organic Chemistry. 77: 1449-1456. PMID 22239739 DOI: 10.1021/Jo202322K  0.663
2012 Kemp MM, Weïwer M, Koehler AN. Unbiased binding assays for discovering small-molecule probes and drugs. Bioorganic & Medicinal Chemistry. 20: 1979-89. PMID 22230199 DOI: 10.1016/J.Bmc.2011.11.071  0.6
2010 Liu R, Xu Y, Chen M, Weïwer M, Zhou X, Bridges AS, DeAngelis PL, Zhang Q, Linhardt RJ, Liu J. Chemoenzymatic design of heparan sulfate oligosaccharides. The Journal of Biological Chemistry. 285: 34240-9. PMID 20729556 DOI: 10.1074/Jbc.M110.159152  0.513
2009 Weïwer M, Chen CC, Kemp MM, Linhardt RJ. Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors. European Journal of Organic Chemistry. 2009. PMID 24223493 DOI: 10.1002/Ejoc.200900117  0.68
2009 Mora-Pale M, Weïwer M, Yu J, Linhardt RJ, Dordick JS. Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorganic & Medicinal Chemistry. 17: 5146-52. PMID 19523836 DOI: 10.1016/J.Bmc.2009.05.061  0.55
2009 Weïwer M, Chen C, Kemp MM, Linhardt RJ. Synthesis and Biological Evaluation of Non-Hydrolyzable 1,2,3-Triazole-Linked Sialic Acid Derivatives as Neuraminidase Inhibitors (Eur. J. Org. Chem. 16/2009) European Journal of Organic Chemistry. 2009: 2587-2587. DOI: 10.1002/Ejoc.200990041  0.668
2009 Weiwer M, Huang F, Chen C, Yuan X, Tokuzaki K, Tomiyama H, Linhardt RJ. ChemInform Abstract: Synthesis and Evaluation of Anticancer Vaccine Candidates: C-Glycoside Analogues of STn and PSA Cheminform. 40. DOI: 10.1002/chin.200934253  0.301
2009 Weiwer M, Sherwood T, Linhardt RJ. ChemInform Abstract: Synthesis of Floridoside. Cheminform. 40. DOI: 10.1002/chin.200920180  0.344
2008 Weïwer M, Sherwood T, Green DE, Chen M, DeAngelis PL, Liu J, Linhardt RJ. Synthesis of uridine 5'-diphosphoiduronic acid: a potential substrate for the chemoenzymatic synthesis of heparin. The Journal of Organic Chemistry. 73: 7631-7. PMID 18759479 DOI: 10.1021/Jo801409C  0.576
2008 Zhang Z, Weïwer M, Li B, Kemp MM, Daman TH, Linhardt RJ. Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. Journal of Medicinal Chemistry. 51: 5498-501. PMID 18754653 DOI: 10.1021/Jm800785T  0.642
2008 Yu J, Weïwer M, Linhardt RJ, Dordick JS. The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases. Current Vascular Pharmacology. 6: 204-17. PMID 18673160 DOI: 10.2174/157016108784911984  0.559
2008 Weïwer M, Sherwood T, Linhardt RJ. Synthesis of Floridoside Journal of Carbohydrate Chemistry. 27: 420-427. DOI: 10.1080/07328300802408843  0.404
Show low-probability matches.